Humana Inc. (HUM) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Me...
Humana Inc.'s revenue increased 10.1% year over year, from $117.76B to $129.66B.
Net income decreased 1.6% over the same period, from $1.21B to $1.19B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 138% in total.
Total debt increased by 5.5% to $12.37B.
The debt-to-equity ratio stands at 0.70, indicating a moderate leverage profile.
Operating cash flow declined 68.9% to $921.0M.
Humana Inc. maintains a moderate net profit margin of 0.9%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $29.40B-0.5% | $480.0M | $728.0M | $1.86B | $50.01B | $13.02B | $17.57B |
| Q4 FY2024 | $29.21B-0.6% | $-693.0M | $-543.0M | $-528.0M | $46.48B | $11.72B | $16.38B |
| Q1 FY2025 | $32.11B+9.9% | $1.24B | $2.01B | $331.0M | $50.93B | $13.31B | $17.75B |
| Q2 FY2025 | $32.39B+0.9% | $545.0M | $1.10B | $1.27B | $50.36B | $12.59B | $18.23B |
| Q3 FY2025 | $32.65B+0.8% | $195.0M | $400.0M | $971.0M | $49.72B | $12.61B | $18.52B |
| Q4 FY2025 | $32.52B-0.4% | $-796.0M | $-808.0M | $-1.65B | $48.91B | $12.37B | $17.66B |
| Q1 FY2026 | $39.65B+21.9% | $1.19B | $1.75B | $1.25B | N/A | N/A | N/A |
| Q2 FY2026 | $40.87B+3.1% | $694.0M | $1.36B | $1.97B | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
Humana Inc. (HUM) Financial Statements & Revenue History
Humana Inc. (HUM) is a US-listed stock operating in the Healthcare sector, specifically the Healthcare Plans industry trading at $415.00 with a market capitalization of $50. This page provides 42 historical financial statements for Humana Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Humana Inc. reported revenue of $129.7 billion, representing 10.1% year-over-year growth. The net profit margin of 0.9% suggests thin margins. The debt-to-equity ratio of 0.70 reflects moderate leverage.
HUM Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Humana Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether HUM is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track HUM's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Humana Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of HUM's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use HUM Financial Data
Investors use Humana Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare HUM's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how HUM's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View HUM's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Humana Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.HUM trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.